Japan Intellectual Property Rights: B7-H4 ANTIBODIES AND METHODS OF USE THEREOF

Japan, Jan. 16 -- FIVE PRIME THERAPEUTICS INC has got intellectual property rights for 'B7-H4 ANTIBODIES AND METHODS OF USE THEREOF.' Other related details are as follows:

Application Number: JP,2024-018525

Category (FI): A61K39/395@E,A61K39/395@T,A61K39/395@U,A61P1/00,A61P11/00,A61P15/00,A61P17/00,A61P35/00,A61P37/06,C07K16/28,C12N1/19,C12N15/13,C12N15/63@Z,C12N5/04,C12N5/10,C12P21/08

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Feb. 9, 2024

Publication Date: March 27, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.